BioXcel Therapeutics, Inc.
Pharmaceutical company · New Haven, Connecticut, United States · Nasdaq: BTAI
BioXcel Therapeutics, Inc. is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its shares trade on Nasdaq under the ticker BTAI.
Profile compiled from public records. Is this your company? Request a correction or update
BioXcel Therapeutics at a glance
Typepharmaceutical company
HeadquartersNew Haven, Connecticut, United States
Stock listingNasdaq: BTAI
SEC industryPharmaceutical Preparations
SEC CIK1720893
Frequently asked questions about BioXcel Therapeutics
Where is BioXcel Therapeutics headquartered?
BioXcel Therapeutics, Inc. is headquartered in New Haven, Connecticut, United States.
What does BioXcel Therapeutics do?
BioXcel Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is BioXcel Therapeutics a public company?
Yes. BioXcel Therapeutics, Inc. trades on Nasdaq under the ticker BTAI.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Trevi Therapeutics, Inc.New Haven, Connecticut, United States
- Veradermics, IncNew Haven, Connecticut, United States
- Rallybio CorpNew Haven, Connecticut, United States
- Achillion Pharmaceuticals IncNew Haven, Connecticut, United States
- Biohaven Ltd.New Haven, Connecticut, United States
- Biohaven Pharmaceutical Holding Co Ltd.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences